Novartis transforms drug business via deals with GSK and Lilly

Swiss drugmaker Novartis is transforming its business by exchanging certain assets with GlaxoSmithKline and divesting its animal health business to Eli Lilly in deals worth billions of dollars.



from News Nation http://ift.tt/1myipkL

via IFTTT